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Background: Many of the assessment tools used to study depression among older people are adaptations of
instruments developed in other cultural setting. There is a need to validate those instruments in low and middle
income countries (LMIC).
Methods: A one-phase cross-sectional survey of people aged [greater than or equal to] 65 years from LMIC. EURO-D
was checked for psychometric properties. Calibration with clinical diagnosis was made using ICD-10. Optimal cutpoint
was determined. Concurrent validity was assessed measuring correlations with WHODAS 2.0.
Results: 17,852 interviews were completed in 13 sites from nine countries. EURO-D constituted a hierarchical scale in
most sites. The most commonly endorsed symptom in Latin American sites was depression; in China was sleep
disturbance and tearfulness; in India, irritability and fatigue and in Nigeria loss of enjoyment. Two factor structure
(affective and motivation) were demonstrated. Measurement invariance was demonstrated among Latin American and
Indian sites being less evident in China and Nigeria. At the 4/5 cutpoint, sensitivity for ICD-10 depressive episode was
86% or higher in all sites and specificity exceeded 84% in all Latin America and Chinese sites. Concurrent validity was
supported, at least for Latin American and Indian sites.
Conclusions: There is evidence for the cross-cultural validity of the EURO-D scale at Latin American and Indian settings
and its potential applicability in comparative epidemiological studies.
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Depression is a common and burdensome psychiatric
disorder in older people [1-3]. In Low and Middle In-
come Countries (LMIC) it is difficult to assess its preva-
lence because of the lack of culturally adapted and
validated assessments.
Clinical diagnostic criteria for depression including
DSM-5 [4] and ICD-10 [5] are applied to adults of all
ages. These may, however, miss clinically significant
episodes among older people who do not meet these
specific criteria. Some investigators have suggested a
syndrome of depression without sadness, thought to be
more common in older adults [6,7], and a depletion* Correspondence: mariella.guerra.1066@gmail.com
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unless otherwise stated.syndrome manifested by withdrawal, apathy, and lack of
vigour [8,9].
Depression symptom scales have been widely used in
population surveys to quantify depression burden as a
continuum, or to screen for depression of clinical signifi-
cance in the first phase of a two phase survey design
[10-15]. However, only the Geriatric Depression Scale
[10,11] and the EURO-D [12] were developed specifically
for use in older people, and evidence for their validity
comes mainly from high income countries [16-21] [12,22].
We set out to assess the construct validity of the
EURO-D in large population-based survey samples of
older people living in Latin America, India, China and
Nigeria, aiming to assess whether this scale measures
the same construct in low and middle income countries
with diverse cultures and languages. Measurement in-
variance would be supported by similar measurement
properties, and a common ‘nomological net’ of proxim-
ate identifiers of the depression symptom score.This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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Setting, design and procedures
Comprehensive, one-phase, catchment area population-
based surveys were conducted according to the same
standardised protocol by the 10/66 Dementia Research
Group. The full 10/66 study protocol has been published
elsewhere [23]. Surveys were carried out in thirteen sites
from nine countries (Cuba, Dominican Republic, Puerto
Rico, Peru, Mexico, Venezuela, China, India and Nigeria).
Peru, Mexico, China and India included both urban and
rural catchment areas; the Nigerian catchment area was
predominately rural, while in the other countries partic-
ipants were recruited only from urban catchment areas.
All assessments were carefully translated and adapted
into the relevant local languages. All the EURO-D items
are derived from the GMS, which is part of the 10/66
assessment. All aspects of assessment methodology, in-
cluding translation and adaptation have been reported
in detail in a previous publication [24]. In brief, the
GMS was translated and back translated into Spanish,
Mandarin, Hindi, Tamil and Ibo. Meta-analysis of 26
publications of exploratory factor analysis of the GDS
reported ‘strong evidence of language differences in the
factor structure of the GDS’, being language strongly
confounded by other aspects of culture [25]. Acceptabil-
ity and conceptual equivalence were assessed and re-
viewed by local informants. Interviews were carried out
in participants’ own homes and lasted on average two
to three hours. Interviewers were fully trained on the
10/66 protocol by the local principal investigator (PI)
and the local study coordinator (SC). The study proto-
col and the consent procedures, including the witnessed
consent procedure, were approved by the King's College
London research ethics committee and in all local
countries: 1- Medical Ethics Committee of Peking
University the Sixth Hospital (Institute of Mental
Health, China); 2- the Memory, Depression Institute
and Risk Diseases (IMEDER) Ethics Committee (Peru);
3- Finlay Albarran Medical Faculty of Havana Medical
University Ethical Committee (Cuba); 4- Hospital
Universitario de Caracas Ethics Committee (Venezuela);
5- Ethics Committee of Nnamdi Azikiwe University
Teaching Hospital (Nigeria); 6- Consejo Nacional de
Bioética y Salud (CONABIOS, Dominican Republic); 7-
Christian Medical College (Vellore) Research Ethics
Committee (India); 8- Instituto Nacional de Neurología
y Neurocirugía Ethics Committee (Mexico); 9-Nnamdi
Azikiwe University Teaching Hospital Nnewi Anambra
State Ethics Committee, Nigeria. Participants were re-
cruited on the basis of informed signed or witnessed
consent; 9-. Ethics committes approved the witnessed
consent procedure. The use of the 10/66 Dementia
Research Group dataset was approved by the 10/66
principal investigators.Depression assessment
Depression was assessed using the Geriatric Mental
State (GMS) [26]. Symptoms are ascertained with re-
spect to the last one month. Internationally, the GMS is
the most widely used comprehensive clinical mental
health assessment for older people. A computerised
diagnostic algorithm, the AGECAT (Automated Geriatric
Examination for Computer Assisted Taxonomy), groups
symptoms to form patterns recognised by a psychiatrist
as illness, and identifies them as syndrome cases [27].
Items are later added together to generate affective dis-
order diagnoses according to ICD-10, and DSM-IV cri-
teria [26,28]. The reliability and validity of the GMS has
been demonstrated for in-patient, out-patient and com-
munity samples, and in various languages and cultures
including Spanish and Chinese. The validity of the
GMS/AGECAT algorithm has been investigated in sev-
eral studies [29,30].
The EURO-D symptom scale was originally developed
to compare symptoms of late-life depression across 11
European countries in the EURODEP Concerted Action
Programme [12]. The 12 EURO-D items (depressed
mood, pessimism, wishing death, guilt, sleep, interest, ir-
ritability, appetite, fatigue, concentration, enjoyment and
tearfulness) were all taken from the Geriatric Mental
State [31]; each item is scored 0 (symptom not present)
or 1 (symptom present), generating a simple ordinal
scale with a maximum score of 12. In the EURODEP
study, internal consistency of the EURO-D, was moder-
ately high with a Cronbach’s alpha ranging from 0.61 to
0.75. However, Principal Components Analysis generated
two factors common to nearly every centre: an affective
suffering factor (depression, tearfulness, pessimism and
wishing death) and a motivation factor (interest, concen-
tration and enjoyment) [12]. The optimum cut-point for
the identification of DSM-IV major depression and
GMS/AGECAT depression was > =4. Evidence for in-
ternal consistency and construct validity of the EURO-D
scale was strengthened following its use in the 10 nation
European Survey of Health, Ageing, and Retirement in
Europe (SHARE) [32]. It was shown to be a hierarchical
scale with similar rank ordering of item calibration values
across countries. The previously observed two factor
structure fitted well in all countries, with similar factor
loadings.
Clinical diagnoses of depressive episode (mild, moder-
ate or severe) were classified according to the Inter-
national Classification of Disease-10 (ICD-10) as a mood
disorder with symptoms of sadness, negative self-regard,
loss of interest in life, and disruptions of sleep, appetite,
thinking, and energy level for more than two weeks that
interfere with daily living [5]. ICD-10 diagnoses were de-
rived from the GMS interview, through the application
of a computerised algorithm.
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We used three indicators to assess the concurrent validity
of the EURO-D:
1. Disability was assessed using the World Health
Organization Disability Assessment Schedule 2.0
(WHODAS 2.0) [33]. It has high internal
consistency, moderate to good test–retest reliability,
and good concurrent validity in many clinical
populations with chronic disease. The robust cross-
cultural measurement properties of the WHODAS
2.0 have been demonstrated in the 10/66 Dementia
Research Group population-based surveys [34];
items formed a unidimensional hierarchical scale in
all sites, with a common underlying factor structure.
2. Happiness was assessed through the response to
GMS question ‘in general, how happy would you say
you are: very happy, fairly happy, not very happy, or
not happy at all?
3. Subjective global health was assessed through the
response to the introductory WHODAS 2.0 question
(not used in the overall disability score) – ‘How do
you rate your overall health in the past 30 days?’
Options were very good, good, moderate, bad and
very bad.
Analyses
We used the 10/66 data archive (release 3.0) for all
analyses.
EURO-D total scale score distributions were sum-
marised according to their mean, median and interquar-
tile range, after inspecting histograms and box plots.
The internal consistency of the scale was assessed in
each site using Cronbach’s alpha. For each site, the pro-
portion of participants endorsing each of the 12 items
(‘item difficulties’) was reported and ranked from 1 (the
most frequently endorsed item) to 12 (the least fre-
quently endorsed item) by site.
Mokken analysis was used to test the extent to which
the EURO-D items conformed to hierarchical scaling
principles in each site. Mokken scaling involves the ap-
plication of a non-parametric item response model [35]
to measure the hierarchical properties of items in a
scale, assessing if the items can be ordered by degree of
difficulty, so that any individual who endorses a particu-
lar item will also endorse all the items ranked lower in
difficulty. Three basic assumptions are required for a
monotone homogeneity model (MHM): 1) unidimen-
sionality (one latent variable summarises the variation in
the item scores in the questionnaire), 2) local independ-
ence (after conditioning on the position on the latent
trait, the item scores are statistically independent), and
3) monotonicity (for all items the probability of a posi-
tive response increases monotonically with increasingvalues of the latent trait). These assumptions being met,
an individual’s position on the latent trait can conveni-
ently be estimated as the rank of the highest item in the
hierarchy that they endorse, or their total number of
positive responses [36]. Double monotonicity models
(DMM) require in addition that for any value of the la-
tent trait, the probability of a positive response decreases
with the difficulty of the item. This means that the order
of item difficulties remains invariant over all values of
the latent trait and thus, that the item response function
curves do not intersect [37,38]. To assess single mono-
tonicity, we estimated Loevinger coefficients for each
item (Hi) and for the whole scale (H), where values be-
tween 0.3 and 0.4 suggest weak scalability, values be-
tween 0.4 and 0.5 moderate, and values above 0.5 strong
scalability. We also tested for violations of monotonicity
(using the StataloevH monotonicity command) and non-
intersection (using the StataloevH nipmatrix command)
between pairs of items (minimum violation 0.03, alpha =
0.05), using overall criteria values as an indication of the
likelihood of assumption violation; ≤40 ‘satisfactory’, 40
to 79 ‘questionable violation’, 80 and over ‘strongly sug-
gesting an assumption violation’ [39]. Measurement in-
variance, with respect to hierarchical scale properties
was assessed according to the Spearman (non-paramet-
ric) correlation between item difficulty ranks between all
pairs of sites.
Principal component analysis (PCA) of EURO-D items
was carried out using PASW version 18, and confirma-
tory factor analysis (CFA) using AMOS version 4.0.
For PCA varimax rotation was carried out with an
Eigenvalue of one as initial extraction criterion. The cut
off used to assume that an item loaded on a given factor
was 0.60, with a threshold of 0.50 signifying borderline
loading. Given the a priori hypothesis of an underlying
two-factor solution [40] we then tested and compared
between sites the goodness-of-fit of the two factor solu-
tion identified in the European SHARE survey, using
confirmatory factor analysis. CFA models contain pa-
rameters that are (a) fixed to a certain value, (b) con-
strained to be equal to other parameters, and (c) free to
take on any unknown value [41]. In testing for psycho-
metric invariance across sites, two models were fitted
and then compared for goodness-of-fit; one in which the
factor loadings are unconstrained, that is estimated sep-
arately for all countries, and the second in which they
are constrained to be equal across countries, the null hy-
pothesis being that items load to a similar extent on the
same latent trait or traits across countries. Markedly
superior fit of the first model would challenge the hypoth-
esis of measurement invariance. We assessed goodness-of-
fit using Akaike’s Information Criterion (AIC) [40], the
Tucker-Lewis Index (TLI) [42] and the Root Mean Square
Error of Approximation (RMSEA). The lower the AIC
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values near 1.0 indicate good fit and those greater than
0.90 are considered satisfactory [43,44]; for the RMSEA
values of less than 0.05 indicate close fit and 0.05 to 0.08
reasonable fit for the model [45]. In the final stage of the
analysis, we compared the goodness of fit of the two factor
solution derived from the European SHARE study with
that of a one factor solution, with loadings constrained
across sites.
We assessed the psychometric properties of the
EURO-D scale, in each site, running receiver operating
characteristic (ROC) curve analyses using ICD-10 de-
pressive episode as the reference criterion, plotting sen-
sitivity against false positive rate (1-sensitivity) and
estimated the area under the ROC curve (AUROC) with
95% confidence intervals. To calibrate the EURO-D score
against ICD-10 depressive episode diagnosis, we used
maximum Youden’s index ((sensitivity + specificity)-1) as
the criterion for determining the optimal cut-point in each
site. The optimal cutpoint for most sites was then applied
to all sites, and the sensitivity, specificity and Youden’s
index at that cut-point was reported against ICD-10 de-
pressive episode. It is important to note that the EURO-D
scale score and ICD-10 diagnosis were both derived from
a single GMS interview, administered by the same re-
search worker, with some overlap in the symptoms ascer-
tained. Therefore, this does not represent an independent
validation of the EURO-D scale, but rather an attempt to
compare its calibration with ICD-10 clinical diagnosis
among sites.
The concurrent validity of the EURO-D scale in each
site was assessed by measuring Spearman rank correla-
tions with global self-rated health (an inverse correlation
hypothesised), WHODAS 2.0 disability (a positive cor-
relation hypothesised) and happiness (an inverse correl-
ation hypothesised).
Results and discussion
Results
Sample characteristics
Overall, 17,852 interviews were completed in 13 sites
from nine countries. A high response rate was obtained,
at least 80% in all sites, and exceeding 90% in several
sites. Table 1 summarizes the sample demographic char-
acteristics, by country. Women predominate over men
in all sites. Educational levels varied widely between
sites, the proportion not completing primary education
was higher in sites in India, China and Nigeria in com-
parison to those in Latin America, and was also gener-
ally higher in rural than urban sites.
Histograms of EURO-D score distributions (data not
provided) indicated that the modal score in all sites,
other than urban India, was zero, indicating no depres-
sion symptoms. In all sites the distribution was markedlypositively skewed. In rural India, the score distribution
was biphasic, with peaks at zero to one and five to seven.
Mean scores ranged between 1.7 and 3.2, other than in
urban China (0.5) and rural China (0.2). Median scores
ranged between 1 and 3, and 75th centiles between 3
and 6, other than in urban China (1) and rural China
(0). Relatively high score distributions were seen in the
Dominican Republic, and India.
The internal consistency of the EURO-D scale Cronbach’s
alpha ranged from 0.64 to 0.87, and exceeded 0.70 in al-
most all sites.
EURO-D hierarchical scaling properties
Loevinger’s H coefficients indicated a weak hierarchical
scale in Cuba, Dominican Republic, Puerto Rico and
China, a moderate hierarchical scale in India and a
strong hierarchical scale in Nigeria (Table 2). In Peru,
Venezuela and Mexico, Loevinger’s H coefficient fell just
below the threshold to support hierarchality. In none of
the countries were any significant violations of mono-
tonicity assumptions noted. There were several statisti-
cally significant violations of the more stringent double
monotone homogeneity (non-intersection) assumptions,
but strong evidence of violation was only seen for a mi-
nority of symptoms in certain sites. The pattern of item-
specific Loevinger’s H coefficients and non-intersection
violations did not suggest that any particular items could
be omitted to generate a more effective hierarchical scale
across countries.
The proportion of participants in each site endorsing
each of the EURO-D symptoms is summarized in
Table 3. The symptoms are ranked, within each site, in
order of frequency of endorsement. The prevalence of
individual symptoms and their rank order were similar
across Latin American and Indian sites. The prevalence
of all symptoms was strikingly lower in Chinese sites,
other than tearfulness, which was commonly endorsed
in the rural Chinese site. The rank order of symptoms
was also somewhat different from that observed in Latin
American and Indian sites. The rank order of symptoms
in the Nigerian site was strikingly different from those in
all other sites. Thus, depressed mood was the most com-
monly endorsed symptom in all Latin American sites,
and the second or third most endorsed symptom in In-
dian sites. Sleep disturbance and tearfulness were the
other commonly endorsed symptoms in those sites.
However, in China depressed mood was the fifth en-
dorsed symptom, while the more commonly endorsed
symptoms were sleep disturbance, fatigue and irritability
in urban China and tearfulness, loss of concentration
and loss of interest in rural China. In Nigeria, depressed
mood was the fourth most commonly endorsed item,
the most frequently endorsed items being loss of enjoy-
ment, loss of interest and fatigue. There was more
Table 1 Response proportion, sociodemographic characteristics and EURO-D score distributions by site
Cuba
n = 2944
Dominican
Republic
n = 2011
P Rico
n = 1918
Peru
urban
n = 1381
Peru
rural
n = 552
Venezuela
n = 1965
Mexico
urban
n = 1003
Mexico
rural
n = 1000
China
urban
n = 1160
China
rural
n = 1002
India
urban
n = 1003
India
rural
n = 999
Nigeria
n = 914
Response
proportion
94 % 95% 93% 80% 88% 80% 84% 86% 74% 96% 72% 98% 98%
Age (years)
Mean age
74.8 75.2 76.1 75.0 74.1 72.3 74.4 74.1 73.9 72.4 71.2 72.5 72.6
Missing values (7) (0) (2) (0) (0) (4) (1) (0) (0) (0) (2) (0) (0)
Gender
Female 1913 (64.9) 1325 (65.9) 1289 (67.2) 888 (64.3) 295 (53.4) 1226 (63.4) 666 (66.4) 602 (60.2) 661 (56.9) 556 (55.4) 571 (57.6) 545 (54.5) 539 (58.9)
Missing values (0) (2) (4) (0) (0) (33) (0) (0) (0) (0) (15) (0) 0
Marital status
Never married 275(9.3) 139 (6.9) 118 (6.1) 145 (10.5) 68 (12.3) 189 (9.8) 63 (6.2) 42 (4.2) 3 (0.2) 22 (2.2) 21 (2.1) 5 (0.5) 41 (4.8)
Currently married 1271(43.2 586 (29.3) 931 (48.5) 784 (57.1) 308 (55.9) 921 (47.9) 470 (46.8) 538 (53.8) 829 (71.4) 585 (58.3) 523 (52.2) 481 (48.1) 581 (68.6)
Widowed 928 (31.6) 806 (40.3) 640 (33.3) 367 (26.7) 157 (28.4) 549 (28.5) 395 (39.3) 371 (37.1) 326 (28.1) 394 (39.3) 426 (42.5) 497 (49.7) 225 (26.5)
Separated/divorce 462 (15.7) 465 (23.3) 228 (11.8) 75 (5.4) 18 (3.2) 261 (13.5) 75 (7.4) 48 (4.8) 2 (0.1) 1 (0.1) 32 (3.1) 16 (1.6) 0 (0.0)
Missing values 8 15 4 10 1 45 0 1 0 0 3 0 67
Education level
Did not complete
primary
730 (24.8) 1314 (70.9) 446 (23.1) 127 (9.1) 225 (41.3) 601 (31.2) 581 (57.4) 837 (83.7) 385 (33.1) 693 (69.0) 662 (65.9) 855 (85.5) 678 (74.1)
Missing values 8 19 0 8 8 40 2 0 0 0 2 0 0
Mean EURO-D
score (SD)
2.1 (2.3) 3.0 (2.6) 1.7 (2.0) 2.6 (2.3) 2.4 (2.0) 2.5 (2.4) 2.6 (2.3) 2.3 (2.2) 0.5 (1.2) 0.2 (0.8) 3.2 (2.5) 3.2 (3.1) 2.5 (3.0)
Median EURO-D
score (25th/75th
centile)
1 (0/3) 2 (1/5) 1 (0/3) 2 (1/4) 2 (1/4) 2 (1/4) 2 (1/4) 2 (0/4) 0 (0/1) 0 (0/0) 3 (1/5) 2 (0/6) 1 (0/4)
Cronbach’s alpha 0.77 0.76 0.73 0.71 0.64 0.73 0.72 0.70 0.70 0.74 0.72 0.87 0.87
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Table 2 Mokken analysis
Cuba DR Puerto Rico Peru Venezuela Mexico China India Nigeria
EURO 1 0.56 0.49 0.57 0.43 0.42 0.44 0.44 0.52* 0.43
Depression
EURO 2 0.38 0.25 0.35 0.27 0.24 0.26 0.31 0.49 0.50
Pessimism
EURO 3 0.37 0.35 0.30 0.29 0.31 0.27 0.51 0.38 0.65
Wishing death
EURO 4 0.25 0.25 0.23 0.23 0.17 0.18 0.47 0.22 0.53
Guilt
EURO 5 0.33 0.33 0.29 0.24 0.31 0.24 0.23 0.46 0.45
Sleep
EURO 6 0.42 0.33* 0.39 0.28 0.36* 0.32 0.38 0.43 0.59
Interest
EURO 7 0.18* 0.25* 0.27 0.11* 0.22 0.15 0.31 0.37 0.50
Irritability
EURO 8 0.29 0.28* 0.20 0.22 0.18* 0.18 0.25 0.43 0.26*
Appetite
EURO 9 0.33 0.32 0.44 0.22 0.27 0.25 0.30 0.29* 0.43
Fatigue
EURO 10 0.25 0.18 0.20 0.22 0.27 0.19 0.09 0.30 0.56
Concentration
EURO 11 0.42 0.33* 0.45 0.30* 0.39 0.37 0.34 0.44 0.71
Enjoyment
EURO 12 0.39* 0.37 0.42 0.31 0.32* 0.34 0.41 0.44 0.55
Tearfulness
Loevinger’s coefficient H 0.35 0.31 0.33 0.26 0.29 0.26 0.31 0.41 0.51
Item-specific and scale Loevinger’s H coefficients, by country, with violations of monotonicity and non-intersection assumptions.
*p = 0.01 to <0.05.
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endorsed symptoms, which tended to be guilt, wishing
death, and (other than Nigeria) loss of enjoyment. The
correlations between pairs of sites in the rank orders of
item prevalences are presented in Table 4. Spearman
rank correlations generally exceed 0.70 among Latin
American sites. While the correlation between rank or-
ders for the two Chinese sites is high and statistically
significant (0.69), those with Latin American sites lie
generally in the range 0.40 to 0.60. Correlations between
the rank order of symptom endorsement in Nigeria and
those in other sites are generally close to zero, although
those with urban China (0.45) and rural China (0.35) are
somewhat higher.
Factor structure
Bartlett’s tests of sphericity and Kaiser-Meyer-Olkin
Measure of Sampling Adequacy suggested that factor
analysis was appropriate and feasible in all countries
(Table 5). The principal components factor analysisyielded three factors with eigenvalues over one in most
countries, with a two factor solution in Cuba, and a four
factor solution in Mexico. The first two factors domi-
nated in all countries (cumulative variance 36.4-45.8%).
The third factors contributed between 8.4% and 9.3% of
scale variance, with eigenvalues between 1.0 and 1.1. In
most countries, the first factor was dominated by load-
ings of the depression and tearfulness items (seven
countries), accompanied by lower level and less consist-
ent loadings from items addressing suicidality (five
countries), and sleep, appetite and pessimism (four
countries each). The second factor was most commonly
dominated by loadings of interest and enjoyment items
(eight countries), with occasional lower level loadings of
concentration (three countries). In Venezuela the second
factor was dominated by depression and tearfulness, and
the third by enjoyment and interest, while in Nigeria the
pattern was reversed. In both of these countries the first
factor was dominated by pessimism and concentration,
with guilt and suicidality also loading in Nigeria. In other
Table 4 Non-parametric correlations between pairs of sites for rank orders of EURO-D item difficulties
Cuba DR Puerto
Rico
Peru
urban
Peru
rural
Venezuela Mexico
urban
Mexico
rural
China
urban
China
rural
India
urban
India
rural
Nigeria
Cuba 1.00 0.83** 0.83** 0.72** 0.54 0.87*** 0.80** 0.67* 0.56 0.19 0.82** 0.74** 0.05
DR 1.00 0.84** 0.75** 0.64* 0.89*** 0.83** 0.42 0.56 0.38 0.73** 0.73** 0.40
Puerto Rico 1.00 0.83** 0.74** 0.93*** 0.97*** 0.56 0.40 0.09 0.85** 0.77** −0.07
Peru urban 1.00 0.92** 0.89*** 0.87*** 0.51 0.53 0.37 0.83** 0.71** 0.06
Peru rural 1.00 0.76** 0.80** 0.43 0.37 0.35 0.75** 0.62* −0.06
Venezuela 1.00 0.91*** 0.56 0.59* 0.33 0.83** 0.77** 0.12
Mexico urban 1.00 0.59* 0.46 0.12 0.83** 0.84** 0.03
Mexico rural 1.00 0.69* −0.38 0.76** 0.78** −0.03
China urban 1.000 0.04 0.69* 0.75** 0.43
China rural 1.00 0.03 −0.07 0.35
India urban 1.00 0.87*** −0.08
India rural 1.00 0.18
*p = 0.01 to <0.05.
**p = 0.001 to <0.01.
***p <0.001.
Table 3 Prevalence (%) of EURO-D symptoms, by site and rank order of item difficulties
Cuba DR Puerto
Rico
Peru
urban
Peru
rural
Venezuela Mexico
urban
Mexico
rural
China
urban
China
rural
India
urban
India
rural
Nigeria
EURO 1 39.6 50.5 39.7 44.0 45.6 39.5 41.5 40.7 3.6 1.6 44.0 42.9 28.5
Depression (1) (1) (1) (1) (1) (1) (1) (1) (5) (5) (2) (3) (4)
EURO 2 25.3 23.4 11.1 15.1 11.1 24.6 29.8 28.0 6.3 0.9 33.5 46.3 20.4
Pessimism (3) (5) (6) (7) (7) (6) (5) (2) (4) (9) (5) (2) (6)
EURO 3 14.0 15.2 7.9 8.8 7.1 9.0 12.3 14.5 1.4 0.6 24.4 16.9 9.4
Wishing death (7) (11) (8) (11) (11) (10) (9) (6) (10) (11) (7) (8) (12)
EURO 4 3.1 4.5 6.1 9.7 8.8 5.0 9.4 7.3 0.3 0.3 7.5 3.0 12.2
Guilt (12) (12) (10) (10) (10) (12) (10) (9) (12) (12) (12) (12) (9)
EURO 5 33.1 39.2 22.2 26.5 10.8 35.9 30.2 25.3 10.6 1.0 34.3 41.0 22.6
Sleep (2) (3) (3) (5) (8) (2) (4) (3) (1) (8) (4) (4) (5)
EURO 6 9.0 18.0 3.6 11.1 8.9 10.8 6.8 7.3 3.5 2.0 9.0 8.3 34.8
Interest (9) (9) (11) (8) (9) (9) (11) (9) (6) (3) (10) (9) (2)
EURO 7 18.4 20.5 14.3 33.1 33.6 25.9 23.3 24.8 8.6 1.4 48.7 34.7 9.7
Irritability (5) (6) (5) (3) (2) (5) (6) (4) (3) (7) (1) (5) (11)
EURO 8 8.6 18.9 9.3 10.1 16.1 11.0 15.8 13.3 2.5 0.7 19.7 26.1 17.3
Appetite (11) (8) (7) (9) (6) (8) (7) (7) (8) (10) (8) (6) (7)
EURO 9 17.6 35.2 20.9 36.0 31.2 31.1 34.3 24.5 9.4 1.6 35.4 61.5 29.2
Fatigue (6) (4) (4) (2) (3) (4) (2) (5) (2) (5) (3) (1) (3)
EURO 10 10.3 17.0 7.8 23.6 25.9 21.4 15.7 10.7 2.0 6.8 18.3 7.8 12.0
Concentration (8) (10) (9) (6) (5) (7) (8) (8) (9) (2) (9) (10) (10)
EURO 11 9.0 19.3 2.7 6.8 7.1 8.4 5.4 5.1 2.6 1.8 7.9 6.4 39.4
Enjoyment (9) (7) (12) (12) (11) (11) (12) (11) (7) (4) (11) (11) (1)
EURO 12 22.7 40.3 33.9 30.5 30.2 34.5 34.0 2.9 1.0 34.9 29.9 25.8 15.2
Tearfulness (4) (2) (2) (4) (4) (3) (3) (12) (11) (1) (6) (7) (8)
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Table 5 Principal components analysis (eigenvalues greater than one) by country
Country 1st Factor items
loading > =0.60 and
0.50-0.59 (*)
2nd factor items
loading > =0.60
and 0.50-0.59 (*)
Number of
factors with
eigenvalues >1.0
Items loading on
other factors > =0.60
and 0.50-0.59 (*)
Cuba KMO = 0.82 Variance = 29.7 Variance = 10.4 2
Bartlett’s p < 0.001 Depression, Tearfulness Pessimism,
Suicidality*
Enjoyment, Interest
Concentration*, Fatigue*
Dominican KMO = 0.80 Variance = 27.9 Variance = 10.7 3 Guilt Suicidality
Republic Bartlett’s p < 0.001 Depression, Sleep, Fatigue Enjoyment, Interest
Appetite*, Tearfulness* Pessimism*
Puerto Rico KMO = 0.78 Variance = 26.2 Variance = 11.0 3 Guilt, Suicidality
Bartlett’s p < 0.001 Depression, Tearfulness Enjoyment, Interest Irritability*
Appetite*, Sleep*, Fatigue* Concentration*
Peru KMO = 0.74 Variance = 24.3 Variance = 12.1 3 Irritability
Bartlett’s p < 0.001 Depression, Tearfulness Interest Guilt*
Suicidality*, Pessimism*, Appetite* Enjoyment
Venezuela KMO = 0.73 Variance = 26.2 Variance = 11.1 3 Enjoyment
Bartlett’s p < 0.001 Pessimism, Concentration Depression Interest
Fatigue*, Sleep*, Irritability* Tearfulness
Mexico KMO = 0.72 Variance = 24.6 Variance = 11.8 4 Appetite
Bartlett’s p < 0.001 Depression, Tearfulness Enjoyment Guilt, Sleep*, Fatigue*
Suicidality, Pessimism Interest Irritability*, Concentration*
China KMO = 0.80 Variance = 31.2 Variance = 12.2 3 Sleep, Appetite*
Bartlett’s p < 0.001 Tearfulness, Suicidality Enjoyment, Interest Fatigue*
Depression Concentration*
India KMO = 0.80 Variance = 32.2 Variance = 13.6 3 Guilt
Bartlett’s p < 0.001 Depression, Pessimism, Sleep Enjoyment
Tearfulness, Appetite*, Irritability* Interest
Nigeria KMO = 0.84 Variance = 42.4 Variance = 13.1 3 Depression, Tearfulness
Bartlett’s p < 0.001 Pessimism, Concentration Enjoyment Sleep, Irritability*
Guilt, Suicidality Interest
Pooled KMO = 0.80 Variance = 29.5 Variance = 11.4 2
Bartlett’s p < 0.001 Depression, Tearfulness, Enjoyment
Pessimism*, Sleep*, Suicidality*,
Irritability*
Interest
*Means: p < 0.001.
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guilt, with or without suicidality and irritability (five
countries). In China, the third factor was loaded upon
by somatic items, sleep, appetite and fatigue.
Given that the findings from the PCA were broadly
consistent with the two factor (affective suffering and
motivation) model previously identified and found to fit
well across European SHARE study countries, we for-
mally tested the goodness of fit of this factor structure
across 10/66 countries, using confirmatory factor ana-
lysis (Table 6). This two factor model showed a moder-
ately good fit across sites according to RMSEA (<0.05),
although less convincingly so according to TLI (0.77,much lower than 0.90, considered acceptable) (Table 7).
The models in which loadings were constrained to be
equal across countries, and which were freely estimated
in each country varied little in terms of AIC, TLI or
RMSEA, suggesting measurement invariance. Variance
in factor loadings was reduced for affective suffering
items when Nigeria (a clear outlier) was omitted, and
the model fit of the two factor solution was clearly im-
proved. When the model fit of the constrained two fac-
tor model (omitting Nigeria) was compared with that of
a one factor solution (omitting Nigeria), the two factor
solution was clearly superior according to all absolute
and relative goodness of fit indices.
Table 6 Confirmatory factor analysis for affective and motivation factors
Affective suffering factor loading Motivation factor loading Factor
correlationCountry Dep Tear Suic Sleep Guilt Irrit Fatigue Interest Enjoyment Pessimism Conc
Cuba 1 0.77 0.44 0.48 0.09 0.25 0.40 1 0.99 0.83 0.47 0.55
DR 1 0.91 0.47 0.64 0.12 0.46 0.60 1 1.11 0.56 0.36 0.51
Peru 1 0.87 0.25 0.38 0.22 0.22 0.36 1 0.76 0.38 0.52 0.30
Venezuela 1 0.85 0.23 0.44 0.08 0.30 0.36 1 0.91 0.29 0.47 0.37
Mexico 1 0.84 0.28 0.35 0.14 0.24 0.38 1 0.91 0.55 0.39 0.31
PR 1 0.84 0.24 0.39 0.15 0.31 0.34 1 0.89 1.14 0.89 0.48
India 1 0.82 0.47 0.74 0.08 0.59 0.38 1 0.88 0.42 0.37 0.31
China 1 0.77 0.49 0.54 0.09 0.74 0.58 1 0.76 0.33 0.26 0.48
Nigeria 1 1.09 0.86 1.03 0.91 0.76 0.87 1 1.13 0.53 0.39 0.66
Mean (SD) - 0.86 (0.10) 0.41 (0.20) 0.55 (0.22) 0.21 (0.27) 0.43 (0.22) 0.47 (0.18) 1 0.93 (0.13) 0.56 (0.27) 0.46 (0.17) 0.44 (0.13)
Mean (SD) omitting Nigeria - 0.83 (0.05) 0.36 (0.12) 0.50 (0.14) 0.12 (0.05) 0.39 (0.19) 0.43 (0.10) 1 0.90 (0.11) 0.56 (0.29) 0.47 (0.19) 0.41 (0.10)
Constrained model 1 0.83 0.39 0.53 0.12 0.39 0.45 1 0.93 0.50 0.41 0.54
Constrained model omitting Nigeria 1 0.82 0.37 0.50 0.11 0.37 0.42 1 0.90 0.50 0.42 0.53
One factor solution omitting Nigeria 1 0.81 0.48 0.63 0.12 0.46 0.55 0.40 0.35 0.68 0.31 -
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Table 7 Confirmatory factor analysis model fit
Two factor solution One factor solution
Model 1 Model 2 Model 3 Model 4 Model 5
Unconstrained Constrained Unconstrained
(excluding Nigeria)
Constrained
(excluding Nigeria)
Constrained
(excluding Nigeria)
X2 7594.7 9148.1 6314.6 7438.6 13760.2
DF 387 459 344 407 422
AIC 8008.7 9418.1 6682.6 7680.6 13972.2
TLI 0.77 0.77 0.79 0.79 0.62
RMSEA 0.03 0.03 0.03 0.03 0.04
Model comparison 2 vs 1 4 vs 3 5 vs 4
X2 change 1553.4 1124.0 6321.6
DF change 72 63 15
X2 change/DF change 21.6 17.8 421.4
DF = Degrees of freedom.
AIC = Akaike Information Criterion.
TLI = Tucker-Lewis Index.
RMSEA = Root mean Square Error Approximation.
Guerra et al. BMC Psychiatry  (2015) 15:12 Page 10 of 14Calibration against clinical diagnoses
The calibration of the EURO-D depression against ICD-
10 clinical diagnosis is summarized in (Table 8). The
Area Under the Receiver Operating Characteristic curve
(AUROC) ranged from 0.89 and 1.00. The optimal cut-
point for the EURO-D against the reference criterion of
ICD-10 depressive episode (using the criterion of maxi-
mizing Youden’s index), was 4/5 (a score of five or more)
in all of the Latin American sites, rural China andTable 8 Psychometric properties of EURO-D depression scale,
ICD-10 depressive episode
AUROC1 Optimal cutpo
(Youden’s inde
Cuba 0.97 (0.96-0.98) 4/5 0.85
DR 0.95 (0.94-0.96) 4/5 0.78
Puerto Rico 0.97 (0.96-0.98) 4/5 0.90
Peru urban 0.94 (0.93-0.96) 4/5 0.77
Peru rural 0.96 (0.94-0.98) 4/5 0.87
Venezuela 0.95 (0.94-0.97) 4/5 0.79
Mexico urban 0.93 (0.91-0.96) 4/5 0.74
Mexico rural 0.94 (0.92-0.97) 4/5 0.76
China urban 1.00 (0.99-1.00) 6/7 0.99
China rural 1.00 (0.99-1.00) 4/5 0.87
India urban 0.95 (0.92-0.98) 5/6 0.74
India rural 0.89 (0.86-0.91) 3/4 0.63
Nigeria 0.93 (0.87-0.98) 4/5 0.79
1AUROC - Area Under the Receiver Operating Characteristic curve.
2Defined by maximizing Youden’s index.Nigeria. While a lower cutpoint (3/4) would have been
selected in rural India, and a higher cutpoint in urban
China (6/7) and urban India (5/6), there was actually lit-
tle difference between Youden’s index at these cutpoints
and at the 4/5 cutpoint that was optimal for other sites.
At the 4/5 cutpoint, the sensitivity for ICD-10 depressive
episode was 86% or higher in all sites and the specificity
exceeded 84% in all Latin American and Chinese sites.
However, specificity was lower in urban India (74.1%),by site, with respect to clinical criteria
int2
x)
Sensitivity at 4/5
cutpoint (%)
Specificity at 4/5
cutpoint (%)
97.2 87.7
93.5 84.0
97.9 91.6
92.0 84.5
100.0 87.0
94.4 84.7
89.4 84.1
88.9 87.0
100.0 97.8
85.7 99.6
97.4 74.1
91.3 69.5
100.0 79.3
Table 9 Construct (concurrent) validity of EURO-D scale
Global self-rated
health
Disability
(WHODAS 2.0)
Happiness
Cuba −0.36 +0.41 −0.49
DR −0.43 +0.48 −0.32
Peru urban −0.45 +0.46 −0.41
Peru rural −0.20 +0.37 −0.17
Venezuela −0.42 +0.47 −0.24
Mexico urban −0.36 +0.33 −0.43
Mexico rural −0.32 +0.32 −0.42
Puerto Rico −0.43 +0.41 −0.42
India urban −0.35 +0.37 −0.30
India rural −0.27 +0.42 −0.39
China urban −0.10 (p = 0.001) +0.42 −0.05 (p = 0.12)
China rural −0.06 (p = 0.06) +0.15 −0.01 (p = 0.70)
Nigeria −0.34 +0.38 +0.01 (p = 0.68)
Note: p < 0.001 unless otherwise specified.
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tively high false positive rate using that cutpoint in those
sites.
Concurrent validity
As hypothesized, EURO-D scores were positively corre-
lated with WHODAS 2.0 disability scores in all sites
(+0.15 to +0.48, P < 0.001), Table 9. EURO-D depression
scores were inversely associated with global self-rated
health in all sites, but at a much lower level in urban
China (−0.10, p = 0.001) and rural China (−0.06, p = 0.06)
than in other sites (−0.27 to −0.43, p < 0.001). EURO-D
scores were inversely associated with happiness in all sites
(−0.17 to −0.49, p < 0.001) other than China urban (−0.05,
p = 0.12) and rural (−0.01, p = 0.70), and Nigeria (+0.01,
p = 0.68).
Discussion
The results of these analyses extend the evidence for the
cross-cultural validity of the EURO-D scale, at least to
Hispanic Latin American and Indian settings. We were
able to replicate the two factor structure (‘affective suf-
fering’ and ‘motivation’) previously demonstrated in two
studies in continental Europe [12,32]. Measurement in-
variance (common factor loadings and rank order of
item difficulties) was demonstrated among Latin American
and Indian sites, but the evidence for this was less com-
pelling for Chinese sites, and measurement properties
were quite different in Nigeria. Concurrent validity (hy-
pothesized positive correlations with disability scores,
and negative correlations with subjective health ratings
and happiness) was strongly supported for the Latin
American and Indian sites. However, correlations with
subjective health ratings were weak in China, and thehypothesised negative correlations with happiness were
absent in China and Nigeria.
We assessed the construct validity of the EURO-D in
large, population-based surveys in diverse low and mid-
dle income country settings, including both rural and
urban catchment areas. We used advanced psychometric
techniques – confirmatory factor analysis and item re-
sponse models, as well as concurrent validity and cali-
bration with clinical diagnosis to evaluate cross-cultural
construct validity. Findings are directly comparable with
similar analyses conducted in continental Europe [32,46].
The main limitations of this study are that we did not
carry out a criterion validation using an independent
clinical interview, and we did not assess test-retest, inter-
interviewer or inter-rater reliability for the EURO-D scale
items.
Findings from this study are most directly comparable
with those from the SHARE survey [22] and the EURODEP
consortium studies [47], in which the EURO-D was ad-
ministered to as part of the GMS (EURODEP, nine sites in
eight European countries, older adults aged 65 years and
over), or as a free-standing scale (SHARE, 11 European
countries, older adults aged 50 years and over) in cross-
sectional population-based surveys. In EURODEP, the
mean EURO-D score ranged from 1.3 to 3.6 among coun-
tries, and in SHARE from 1.8 to 3.1, similar to the range
observed in our 10/66 studies of 1.7 to 3.2 (excluding the
low outlier of China). Cronbach’s alpha ranging from 0.61
to 0.75 in EURODEP, and from 0.62 to 0.78 in SHARE,
similar to the range from 0.64 to 0.77 observed in most
10/66 sites. The unusually high internal consistency in
rural India and Nigeria (Cronbach’s alpha, 0.87) may sug-
gest a problem with response set bias in those sites. The
EURO-D demonstrated stronger hierarchical scaling prop-
erties in the European countries included in the SHARE
survey [32] than in the 10/66 sites in Latin America and
India. Nevertheless, the rank of item difficulties was simi-
lar, with depression, sleep disturbance and fatigue being
among the most commonly endorsed items (low item
difficulty), and guilt and wishing death among the least
commonly endorsed (high item difficulty). In Nigeria,
EURO-D item responses were strongly hierarchical but
with a strikingly different rank order of item difficulties
than that observed in the other 10/66 sites and in the
European SHARE survey countries. Principal Components
Analysis generated similar factor structures (affective suf-
fering and motivation) in the current study as in the
EURODEP studies [46], the SHARE surveys [32], and in
convenience samples of depressed and older people from
the general population in the 10/66 Dementia Research
Group pilot studies in Latin America, India and China
[24]. The two factor solution derived in the European
SHARE study fitted moderately well in our current sam-
ple, particularly when the Nigerian site was excluded.
Guerra et al. BMC Psychiatry  (2015) 15:12 Page 12 of 14As in the SHARE study, depression and tearfulness
consistently loaded on Affective Suffering. However, in
contrast to the SHARE study interest and enjoyment
rather than enjoyment and pessimism dominated the
Motivation factor. The clinical diagnosis of ICD-10 de-
pressive episode in the current study was derived from
the same GMS interview, using many of the same items
that were used to score the EURO-D, the distinction be-
ing that particular combinations of symptoms (which
needed to be persistent and pervasive) were required to
meet the ICD-10 criteria. As such, the favourable validity
coefficients cannot be taken as evidence of criterion val-
idity. Such evidence is available from independent clin-
ical assessments in some of the EURODEP studies [12],
a clinical validation of the EURO-D scale in Spain [48]
and high sensitivity for the detection of severe depres-
sion in the 10/66 Dementia Research Group pilot studies
in Latin America, India and China [24]. We were, how-
ever, able to calibrate the EURO-D scale score against a
ICD-10 clinical diagnosis of depressive episode; the opti-
mal cutpoint was 4/5 in most sites, one point higher than
the 3/4 cutpoint identified as optimal in the EURODEP
consortium studies [12,46]. Concurrent validity of the
EURO-D scale has not been assessed in previous studies.
Depression among older people has been previously
shown to be strongly associated with disability [49-51] and
inversely associated with self-reported global health [12].
Although happiness is undoubtedly more than the absence
of depression, recent analyses of population-based survey
data from the United Kingdom, Germany and Australia
indicate that mental ill health accounts for by far the lar-
gest component of the variance in lack of life satisfaction,
dominating the effects of physical health, demographic
and socioeconomic factors [52]. As such, the failure to ob-
serve the predicted inverse correlation with self-reported
happiness in China and Nigeria does not support the con-
struct validity of the EURO-D in those settings.
Several factors may have contributed to the discrepant
measurement characteristics of the EURO-D in China
and particularly Nigeria. In the Chinese sites the preva-
lence of nearly all depression symptoms was strikingly
low. This may have impeded the elucidation of the factor
structure and assessment of hierarchality, as well as lim-
iting the variance to be explained in correlation with
concurrent validators. In China the once popular and
prevalent diagnosis of shenjing shuairuo, a neurasthenia
like syndrome comprising weakness, fatigue, concentra-
tion problems, headache and other somatic symptoms
seems in recent years to have been supplanted as the
most common diagnosis in epidemiological surveys and
clinical practice by depressive and anxiety disorders [53].
This has led some to allege an inappropriate importation
of western nosologies that do not match well with
Chinese cultural idioms of expression of psychologicaldistress [53]. An alternative standpoint is that ‘mental
health literacy’, judged by recognition and appropriate
attribution of vignettes of depression and anxiety, is low
in Chinese populations both inside and outside of China
[54]. In this context, it is perhaps noteworthy that in our
study depression was not a common symptom in either
the urban or rural Chinese sites, and the sleep disturb-
ance, fatigue and irritability were the three commonest
symptoms in the urban site, and tearfulness, lack of con-
centration and loss of interest in the rural site. The
EURO-D factor structure derived from the Chinese sam-
ple is consistent with previous observations from rural
Thailand [55] where a high prevalence of fatigue was
also observed, and where in addition to affective suffer-
ing and motivation, sleep and appetite constituted a sep-
arate third factor.
Cultural differences in the experience, attribution and
communication of psychological distress might also have
mediated some of the observed differences in measure-
ment properties in Nigeria. Brain Fag Syndrome, compris-
ing a tetrad of somatic complaints, cognitive impairments,
sleep related complaints, and other somatic impairments
was recognised as a West African culture bound syn-
drome in DSM-IV [56]. While originally recognised
among students in the early 1960s, it is likely that this
reflects enduring and widespread tendencies for the ex-
pression of psychological distress, informed by cultural
norms and traditional medicine services. In our study,
loss of enjoyment and interest, and fatigue were the most
commonly endorsed symptoms in Nigeria; however, the
rank orders of sleep disturbance and concentration prob-
lems were similar to those in other sites. Site-specific fac-
tors, some of which may have been culture related, may
also have influenced the interaction between the older re-
spondent and the interviewer, impacting on the assess-
ment, ascertainment and recording of symptoms. In
Nigeria, interviewers were local school leavers as opposed
to graduates (often health professionals) in other sites, and
levels of education and literacy among participants were
the lowest of any of the 10/66 survey sites. While training
for interviewing using the GMS was carried out using
standardized and rigorous procedures in all sites, this may
have been a particularly challenging task for the young in-
terviewers in Nigeria. Finally, in both Nigeria and China,
suboptimal translations and or cultural adaptions for ei-
ther the happiness question or the EURO-D may have led
to an underestimation of the correlations between these
variables.
Conclusions
In conclusion, more work needs to be done to establish
the validity of the EURO-D scale, and by extension the
GMS interview, when used across cultures as a tool for
assessing depression symptom severity, and generating
Guerra et al. BMC Psychiatry  (2015) 15:12 Page 13 of 14clinical diagnoses. While its cross-cultural measurement
properties are for the most part favourable, the case for
measurement invariance with respect to its European or-
igins weakens progressively with increasing cultural dis-
tance and disparity in levels of human development.
Different questions, asked in different ways, may have
served better to elicit symptoms of depressed mood in
certain cultures. Ethnographically informed qualitative
research might help to identify culture-specific idioms of
psychological distress (not captured by depression nosol-
ogies), among older adults in China and Nigeria. With
globalisation, and progressive economic and human de-
velopment, it may be that cultures will tend to converge
around a western consensus of ‘mental health literacy’.
If so, one might hypothesise that, through a cohort ef-
fect, cross-cultural challenges may be most evident in
the assessment of the mental health of older adults.
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